What is a stock summary page? Click here for an overview.
Business Description
Cannara Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA13765U2002
Compare
Compare
Traded in other countries / regions
LOVE.CanadaLOVFF.USA8CB0.Germany IPO Date
2019-01-15Description
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 3.16 | |||||
| Interest Coverage | 2.31 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.92 | |||||
| Beneish M-Score | -1.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 59.2 | |||||
| 3-Year EBITDA Growth Rate | 60.7 | |||||
| 3-Year Book Growth Rate | 10.1 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.72 | |||||
| 9-Day RSI | 52.1 | |||||
| 14-Day RSI | 56.15 | |||||
| 3-1 Month Momentum % | 87.33 | |||||
| 6-1 Month Momentum % | 102.48 | |||||
| 12-1 Month Momentum % | 38.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.01 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 253.02 | |||||
| Days Sales Outstanding | 49.44 | |||||
| Days Payable | 77.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -2.82 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.33 | |||||
| Operating Margin % | 10.11 | |||||
| Net Margin % | 7.6 | |||||
| FCF Margin % | 11.13 | |||||
| ROE % | 7.87 | |||||
| ROA % | 4.39 | |||||
| ROIC % | 5.89 | |||||
| 3-Year ROIIC % | 21.18 | |||||
| ROC (Joel Greenblatt) % | 7.24 | |||||
| ROCE % | 7.92 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.57 | |||||
| PE Ratio without NRI | 25 | |||||
| Price-to-Owner-Earnings | 32.5 | |||||
| PS Ratio | 1.36 | |||||
| PB Ratio | 1.29 | |||||
| Price-to-Tangible-Book | 1.29 | |||||
| Price-to-Free-Cash-Flow | 12.15 | |||||
| Price-to-Operating-Cash-Flow | 7.56 | |||||
| EV-to-EBIT | 16.96 | |||||
| EV-to-EBITDA | 10.09 | |||||
| EV-to-Revenue | 1.79 | |||||
| EV-to-FCF | 16.02 | |||||
| Price-to-GF-Value | 0.82 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 46.5 | |||||
| Earnings Yield (Greenblatt) % | 5.9 | |||||
| FCF Yield % | 8.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LOVFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cannara Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 63.693 | ||
| EPS (TTM) ($) | 0.05 | ||
| Beta | 0.35 | ||
| 3-Year Sharpe Ratio | 0.15 | ||
| 3-Year Sortino Ratio | 0.27 | ||
| Volatility % | 71.05 | ||
| 14-Day RSI | 56.15 | ||
| 14-Day ATR ($) | 0.018701 | ||
| 20-Day SMA ($) | 0.919515 | ||
| 12-1 Month Momentum % | 38.54 | ||
| 52-Week Range ($) | 0.387 - 0.99 | ||
| Shares Outstanding (Mil) | 90.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cannara Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cannara Biotech Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cannara Biotech Inc Frequently Asked Questions
What is Cannara Biotech Inc(LOVFF)'s stock price today?
The current price of LOVFF is $0.93. The 52 week high of LOVFF is $0.99 and 52 week low is $0.39.
When is next earnings date of Cannara Biotech Inc(LOVFF)?
The next earnings date of Cannara Biotech Inc(LOVFF) is .
Does Cannara Biotech Inc(LOVFF) pay dividends? If so, how much?
Cannara Biotech Inc(LOVFF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers